Delineation of HER2 Gene Status in Breast Carcinoma by Silver in Situ Hybridization is Reproducible among Laboratories and Pathologists-Reference-Cited by-同舟云学术

Delineation of HER2 Gene Status in Breast Carcinoma by Silver in Situ Hybridization is Reproducible among Laboratories and Pathologists

Published:2008-11 Issue:6 Volume:10 Page:527-536
ISSN:1525-1578
Container-title:The Journal of Molecular Diagnostics
language:en
Short-container-title:The Journal of Molecular Diagnostics

Author:

Carbone Antonino,Botti Gerardo,Gloghini Annunziata,Simone Gianni,Truini Mauro,Curcio Maria Pia,Gasparini Patrizia,Mangia Anita,Perin Tiziana,Salvi Sandra,Testi Adele,Verderio Paolo

Publisher

Elsevier BV

Subject

Molecular Medicine,Pathology and Forensic Medicine

Reference35 articles.

1. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer;Slamon;Science,1989

2. The discovery of receptor tyrosine kinases: target for cancer therapy;Gschwind;Nat Rev Cancer,2004

3. Assignment of c-erb-B2 avian erythroblastic leukemic viral oncogene homolog 2 (ERBB2) to human chromosome band 17121.1 by in situ hybridization;Muleris;Cytogenet Cell Genet,1997

4. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene;Coussens;Science,1985

5. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Image analysis for bright-field HER2 in situ hybridization: validation for clinical use;Virchows Archiv;2024-08-07

2. HER2 in situ hybridization test in breast cancer: quantifying margins of error and genetic heterogeneity;Modern Pathology;2021-05-12

3. Comparative Performance of Breast Cancer Human Epidermal Growth Factor Receptor 2 Fluorescence In Situ Hybridization and Brightfield In Situ Hybridization on College of American Pathologists Proficiency Tests;Archives of Pathology & Laboratory Medicine;2018-05-07

4. Bright-field in situ hybridization detects gene alterations and viral infections useful for personalized management of cancer patients;Expert Review of Molecular Diagnostics;2018-02-21

5. Counting invasive breast cancer cells in the HER2 silver in-situ hybridization test: how many cells are enough?;Histopathology;2017-04-26